Programmed Cell Death 1 Inhibitor
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB15463 | Belzutifan | An inhibitor of hypoxia-inducible factor 2α used as an antineoplastic in the treatment of certain cancers associated with von Hippel-Lindau (VHL) disease. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00062 | Albumin human | 1 | Completed | 1 |
| DB14776 | Camrelizumab | 1 | Completed | 1 |
| DB00515 | Cisplatin | 1 | Completed | 1 |
| DB01229 | Paclitaxel | 1 | Completed | 1 |
| DB14765 | Rivoceranib | 1 | Completed | 1 |
| DB15043 | Toripalimab | 1 | Completed | 1 |